Animals that have myelin basic protein (MBP) specific lymphocytes with a TH1(+) phenotype have worse stroke outcome than those that do not. Whether these MBP specific cells contribute to worsened outcome or are merely a consequence of worse outcome is unclear. In these experiments, lymphocytes were obtained from donor animals one month after stroke and transferred to naïve recipient animals at the time of cerebral ischemia. The MBP specific phenotype of donor cells was determined prior to transfer. Animals that received either MBP specific TH1(+) or TH17(+) cells experienced worse neurological outcome, and the degree of impairment correlated with the robustness of MBP specific TH1(+) and TH17(+) responses. These data demonstrate that the immunologic phenotype of antigen specific lymphocytes influences stroke outcome.
Introduction
Following stroke there is a transient breakdown in the blood-brain barrier (BBB) that allows cells of the immune system to gain access to the brain (Jander et al., 1995) . In addition, dying neurons and glia release proteins into the systemic circulation allowing cells of the immune system to come into contact with CNS specific proteins in the periphery (Jauch et al., 2006) . The possibility for developing an immune response to brain antigens thus exists, and the nature of that response depends upon the microenvironment at the site of antigen presentation. In animal models, we showed that TH1 type immune responses to antigens such as myelin basic protein (MBP) were uncommon after stroke, but that TH1 responses could be enhanced by an inflammatory insult (systemic injection of lipopolysaccharide [LPS] ) during the period of BBB compromise (Becker et al., 2005) . In these experiments, a TH1(+) response to MBP was associated with worse stroke outcome (Becker et al., 2005; Gee et al., 2008 Gee et al., , 2009 . Whether the TH1 response to brain antigens contributed to the poor outcome or was merely a marker of poor outcome has not yet been adequately addressed. In the current study, the influence of lymphocytes primed to MBP by stroke (and injection of LPS) on stroke outcome was assessed by adoptive transfer of these cells to naïve animals. Lymphocytes were harvested from donor animals one month after stroke and injected into recipient animals at the time of middle cerebral artery occlusion (MCAO). The immunologic phenotype of the transferred cells (MBP specific TH1[+] or TH17[+]) was determined and their effect on the outcome of recipients assessed.
Methods

Animals
All protocols were approved by the Institutional Animal Care and Use Committee (IACUC). Donor animals (male Lewis rats, 325-375 g, Charles River) underwent 3 h middle MCAO and received either an intraperitoneal (IP) injection of lipopolysaccharide (LPS; 1 mg/kg) or normal saline (1 mL/kg) at the time of reperfusion. The prolonged period of ischemia (3 h) and LPS was used to skew the immune response towards MBP to that of a TH1(+) response (Becker et al., 2005) . Sham-operated animals underwent ligation of the common carotid artery without MCAO and were similarly treated with either LPS or saline. Donor animals were sacrificed at 1 month after MCAO -the optimal time point to detect the TH1 immune response to MBP based on our prior studies (Becker et al., 2005) . Recipient animals (male Lewis rats, 325-375 g, Charles River) underwent MCAO (2 h) and at the time of reperfusion received an IP injection of splenocytes (1 × 10 8 cells in 1 mL normal saline) from donor animals. Recipient animals received cells from only 1 donor animal and were sacrificed at 1 day, 3 days or 1 week after MCAO (Fig. 1) . Temperature was maintained at normothermia during MCAO, but animals were allowed to spontaneously thermoregulate thereafter. A shorter period of ischemia (2 h) was used in recipient
